Clinical waste may prove valuable for monitoring treatment response in ovarian cancer
A microchip-based device developed by Massachusetts General Hospital (MGH) investigators may greatly simplify the monitoring of patients' response to treatment for ovarian cancer – the most lethal form of gynecologic cancer ...
Dec 6, 2013
0
0